The notice allows a brief transition period during which further orders from Core will be accepted and met.
Theragenics Corporation chairman and CEO Christine Jacobs said that litigation recently filed against Core by a third party led to the current situation.
"We believe there is an unacceptable level of uncertainty surrounding Core’s ability to satisfy their financial obligations to us," Jacobs said.
